Marinus Pharmaceuticals (MRNS) SEC Filings & 10K Form

$1.42
-0.02 (-1.39%)
(As of 04/25/2024 ET)

Recent Marinus Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/19/2024
5:04 AM
Marinus Pharmaceuticals (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
04/15/2024
6:32 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
7:00 AM
Marinus Pharmaceuticals (Filer)
Form DEF 14A
04/04/2024
7:02 AM
Marinus Pharmaceuticals (Filer)
Form DEFA14A
03/27/2024
10:55 AM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
11:18 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
9:35 AM
Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G
02/14/2024
8:04 AM
Avoro Capital Advisors LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
11:13 AM
Marinus Pharmaceuticals (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/08/2024
12:56 PM
JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
02/07/2024
6:25 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/06/2024
10:58 AM
FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
01/19/2024
3:18 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:19 PM
Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:20 PM
Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:21 PM
MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:21 PM
Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:22 PM
Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:23 PM
Austin Charles (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:23 PM
Marinus Pharmaceuticals (Issuer)
Nochur Sara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:25 PM
Fischer Seth H. Z. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:26 PM
Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:27 PM
Marinus Pharmaceuticals (Issuer)
Silverstein Christine Berni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:27 PM
Johnson Marvin (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:28 PM
Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
6:04 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
6:05 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
6:31 AM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
6:11 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
6:05 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2023
7:02 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2023
6:00 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2023
6:00 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
6:55 AM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
6:10 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
8:05 PM
Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
8:05 PM
MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
8:05 PM
Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
8:05 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
8:05 PM
Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
7:45 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.
05/17/2023
8:02 PM
Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/17/2023
8:08 PM
Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2023
7:01 AM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2023
6:03 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MRNS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners